Newsfeeds - Spark Newswire

1 minute read

Legal
News

Actinium Pharmaceuticals Receives Notice Of Allowance For U.S. Patent Titled ‘METHOD FOR TREATING CANCER USING A BCL-2 INHIBITOR IN CONJUNCTION WITH AN ALPHA-EMITTING RADIOIMMUNOTHERAPEUTIC’

By Benzinga Newsdesk

March 23, 1:40 PM

https://patentcenter.uspto.gov/#!/applications/16607168/ifw/docs

ATNM

1 minute read

News

Actinium Pharmaceuticals Granted U.S. Patent #11,241,512 ‘Stabilized radio-labeled anti-CD45 immunoglobulin compositions’

By Charles Gross

February 8, 7:57 AM

View patent here

ATNM

25 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

January 14, 1:30 PM

During Friday's session, 445 companies made new 52-week lows.

AAOI

4 minute read

Actinium Pharmaceuticals, Inc. And EpicentRx Announce Research Collaboration To Combine Targeted Radiotherapies With Next Generation CD47/SIRPα Immunotherapy

By Bill Haddad

January 5, 8:35 AM

- Collaboration builds on recent data presented by Actinium at SITC demonstrating enhanced activity of targeted radiotherapies in combination with the anti-CD47 targeting antibody magrolimab in blood cancer and solid

ATNM

2 minute read

Actinium Pharmaceuticals Reports 2 Remissions And 67% ORR In Patients With A TP53 Mutation In The Phase 1 Portion Of The Actimab-A Venetoclax Combination Trial In Patients With Relapsed Or Refractory AML At The 63rd ASH Annual Meeting

By Benzinga Newsdesk

December 14, 8:49 AM

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for patients with unmet needs today announced that data from the

ATNM

1 minute read

Actinium Pharmaceuticals, Inc. Announces Participation In Two Panel Discussions At 3rd Targeted Radiopharmaceuticals Summit Dec. 9

By Bill Haddad

December 8, 9:26 AM

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for patients with unmet needs announced today its

ATNM

1 minute read

From BZ’s Small Cap Healthcare Conference: Actinium Pharmaceuticals, Inc CFO, Steve O’Loughlin Begins Speaking

By Zoltan Suranyi

September 30, 10:51 AM

Click To Tune In Here... https://www.youtube.com/watch?v=TG5SSZDlpBo

ATNM

1 minute read

News

Actinium Announces Expansion Of R&D Team And Facilities

By Bill Haddad

September 27, 8:07 AM

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for patients with unmet needs, today announced multiple updates

ATNM

4 minute read

48 Biggest Movers From Friday

By Lisa Levin

September 20, 4:58 AM

Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by AstraZeneca for patients with unresectable, stage 3 non-small cell lung cancer.

AKYA

5 minute read

53 Biggest Movers From Yesterday

By Lisa Levin

September 16, 6:57 AM

Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share.

ADGI